Article info

Download PDFPDF

Original research
Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia

Authors

  1. Correspondence to Professor Hubert H Fernandez, Center for Neurological Restoration, Cleveland Clinic Foundation, Cleveland, OH 44195, USA; fernanh{at}ccf.org
View Full Text

Citation

Fernandez HH, Stamler D, Davis MD, et al
Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia

Publication history

  • Received October 30, 2018
  • Revised May 21, 2019
  • Accepted June 18, 2019
  • First published July 10, 2019.
Online issue publication 
April 07, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.